ARTICLE | Politics, Policy & Law
FDA’s hydroxychloroquine test
Editor’s Commentary: FDA’s decision about the hydroxychloroquine EUA is a test of its independence and credibility
May 12, 2020 2:11 AM UTC
Updated on May 12, 2020 at 10:09 PM UTC
COVID-19 is testing FDA’s leadership. The agency’s performance will affect both the health of COVID-19 patients as well as public trust in the agency.
One of many challenges facing FDA is whether to keep in place or rescind an Emergency Use Authorization (EUA) for chloroquine and hydroxychloroquine -- and how to explain its decision. ...